A.p.l. 10000 Unit Liquid ; Powder For Solution is a Health Canada–registered veterinary drug (DIN 00053104) held by Ayerst Veterinary Laboratories, containing Chorionic Gonadotropin. Health Canada lists its status as Cancelled Post Market (status date 08 Sep 2003). Nexara Health has matched 56 registrations of Chorionic Gonadotropin across 16 other regulated markets, 6 of them in the same strength and dosage form.

Health Canada registration

Chorionic Gonadotropin registered in other markets

56 registrations of the same molecule in 16 national registries outside Canada (first 55 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Chorionic Gonadotropin worldwide →

Regulator price references for Chorionic Gonadotropin

Published list or reimbursement prices for Chorionic Gonadotropin presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is A.p.l. (DIN 00053104) marketed in Canada?

No. Health Canada lists DIN 00053104 as Cancelled Post Market as of 08 Sep 2003.

Who holds the Canadian licence for this product?

Ayerst Veterinary Laboratories is the company of record in the Health Canada Drug Product Database.

Is Chorionic Gonadotropin registered outside Canada?

Yes — Nexara Health has matched 56 registrations in 16 other markets, including 6 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00053104, status date 2003-09-08; national medicine registries: CMED, CSG Compendio (formulary), DoH SEP database, EU national register, FDA NDC, FEST (DMP), LINAME (formulary), Lyfjastofnun lyfjaverdskra, NEAK PUPHA, NHRA, NHS dm+d VMP, NPRA, PAMI, SUKL DLP, TITCK, URPL RPL; price sources: CMED, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, NEAK PUPHA, NHRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00053104, status date 2003-09-08; national medicine registries: CMED, CSG Compendio (formulary), DoH SEP database, EU national register, FDA NDC, FEST (DMP), LINAME (formulary), Lyfjastofnun lyfjaverdskra, NEAK PUPHA, NHRA, NHS dm+d VMP, NPRA, PAMI, SUKL DLP, TITCK, URPL RPL; price sources: CMED, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, NEAK PUPHA, NHRA.

Health Canada Drug Product Database (DPD), DIN 00053104, status date 2003-09-08; national medicine registries: CMED, CSG Compendio (formulary), DoH SEP database, EU national register, FDA NDC, FEST (DMP), LINAME (formulary), Lyfjastofnun lyfjaverdskra, NEAK PUPHA, NHRA, NHS dm+d VMP, NPRA, PAMI, SUKL DLP, TITCK, URPL RPL; price sources: CMED, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, NEAK PUPHA, NHRA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.